BIN2 inhibition suppress ovarian cancer progression meanwhile protect ovarian function through downregulating HDAC1 and RPS6 phosphorylation respectively.
Li CR, Xie SY, Zhang SP, Yang YJ, Yang LL, Cao Y, Wang LL, Zhu FY, Wang RL, Yang ZX, Cui CC, Li YR, Xu JN, Yue F, Tian PZ, Wang Q, Yao HJ, Guan YC, Zhang SD, Ying XY, Zhang D, Zhang CL.
Li CR, et al. Among authors: yang ll.
Clin Transl Med. 2024 Oct;14(10):e70051. doi: 10.1002/ctm2.70051.
Clin Transl Med. 2024.
PMID: 39412213
Free PMC article.
No abstract available.